Definitive Healthcare, which provides a SaaS platform to help healthcare companies commercialize, filed on Friday with the SEC to raise up to $100 million.
Definitive Healthcare states that it is a leading provider of healthcare commercial intelligence, offering a platform leveraged by functional groups including sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. The company served over 2,600 customers as of June 30, 2021, which include biopharmaceutical and medical device companies, Healthcare Information Technology companies, healthcare providers, and other diversified companies seeking commercial success in the healthcare ecosystem.
The Framingham, MA-based company was founded in 2011 and booked $140 million in revenue for the 12 months ended June 30, 2021. It plans to list on the Nasdaq under the symbol DH. Goldman Sachs, J.P. Morgan, Morgan Stanley, Barclays, Credit Suisse, and Deutsche Bank are the joint bookrunners on the deal. No pricing terms were disclosed.
